Exact Mass: 494.3066
Exact Mass Matches: 494.3066
Found 500 metabolites which its exact mass value is equals to given mass value 494.3066
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Makisteron A
Makisterone A is a steroid. Makisterone A is a natural product found in Rhodnius prolixus, Dysdercus cingulatus, and other organisms with data available.
(3b,4b,11b,14b)-11-Ethoxy-3,4-epoxy-14-hydroxy-12-cyathen-15-al 14-xyloside
(3b,4b,11b,14b)-11-Ethoxy-3,4-epoxy-14-hydroxy-12-cyathen-15-al 14-xyloside is found in mushrooms. (3b,4b,11b,14b)-11-Ethoxy-3,4-epoxy-14-hydroxy-12-cyathen-15-al 14-xyloside is a constituent of Hericium erinaceum (lions mane) Constituent of Hericium erinaceum (lions mane). (3b,4b,11b,14b)-11-Ethoxy-3,4-epoxy-14-hydroxy-12-cyathen-15-al 14-xyloside is found in mushrooms.
1-docosanoyl-glycero-3-phosphate
1-docosanoyl-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-docosanoyl-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-docosanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(22:0/0:0)
LysoPA(22:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(22:0/0:0), in particular, consists of one chain of behenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(i-22:0/0:0)
LysoPA(i-22:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-22:0/0:0), in particular, consists of one chain of isodocosanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
PA(8:0/13:0)
PA(8:0/13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/13:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of tridecylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/a-13:0)
PA(8:0/a-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/a-13:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of anteisotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/i-13:0)
PA(8:0/i-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-13:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
milbemycin beta3
1-(2,6-Dihydroxyphenyl)-9-[4-hydroxy-3-(p-menth-1-en-8-yloxy)phenyl]-1-nonanone
2-O-(2-methylbutyryl)-3-O-acetyl-alpha-bisabolol-beta-D-fucopyranoside|2-O-<2-methylbutyryl>-3-O-acetyl-alpha-bisabolol-beta-D-fucopyranoside
9,10-epoxy-5beta-O-acetyl-6alpha-O-tigloyl-7alphaH-8beta-O-(3-hydroxy-2-methylbutyryl)germacra-3(4)E-ene|trijugin G
8-hydroxy-labda-13(16),14-dien-19-yl-O-acetyl-trans-coumarate
8beta-hydroxy-15-malonyloxy-18-angeloyloxy-ent-labdane
16-O-??-L-Arabinofuranoside-3, 16-Dihydroxy-13(17)-mansumbinen-28-oic acid
4,9-di-furan-3-yl-1,6a,6b,12-tetramethyl-hexadecahydro-thieno[2,3-b;5,4-b]diquinolizine|Neothiobinupharidin|Thio-binupharidin|Thiobinupharidin
5alpha-pregn-6-ene-3beta,17alpha,20(S)-triol-3-O-beta-D-digitalopyranoside|teikagenin-3-O-beta-D-digitaloside
15alpha,20beta-Dihydroxy-Delta4-pregnen-3-one-glucoside
8beta-hydroxy-15-malonyloxy-18-senecioyloxy-ent-labdane
3beta-acetoxyglutina-5(10),6-dien-27,8alpha-olide|phyllenolide A
(4aS)-1t,9t-di-furan-3-yl-4c,6a,12c,14a-tetramethyl-(4ar,6at,7ac,12ac,14at,15at)-hexadecahydro-[1,4]dioxino[2,3-c;5,6-c]diquinolizine|6beta,7beta-epoxy-deoxynupharidine dimer
3-O-methyl-6-oxopristimerol|methyl (2R,4aS,6aS,12bR,14aS,14bR)-1,2,3,4,4a,5,6,6a,8,12b,13,14,14a,14b-tetradecahydro-11-hydroxy-10-methoxy-2,4a,6a,9,12b,14a-hexamethyl-8-oxopicene-2-carboxylate
butremycin
A polyketide macrolactam containing a tetramic acid (pyrrolidine-2,4-dione) ring system. It is the 3-hydroxyl derivative of ikarugamycin and isolated from Micromonospora sp. K310.
1beta,3beta,14alpha,20beta,22beta,25-hexahydroxy-5beta-ecdysteroid|aervecdysteroid C
(1R,2R,3E,7E,11R,12S)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)dolabella-3,7-dien-2,16,18-triol
21S,23R-21,23:23,27-diepoxy-21-methoxycycloartan-1,24-diene-3,27-dione
1-(3,7-dimethylocta-2,6-dienyl)-6,6,10,10-tetramethyl-11-(2-methylpropanoyl)tetracyclo[7.3.1.13,11.03,7]tetradecane-2,12,14-trione|hypersampsone C
3-O-beta-D-glucopyranosyl-3beta,15alpha-dihydroxypregn-5-en-20-one
9,10-epoxy-5beta-O-tigloyl-7alphaH-8beta-O-(3-acetoxy-2-methylbutyryl)germacra-3(4)E-en-6alpha-ol|trijugin D
9,10-epoxy-6alpha-O-tigloyl-7alphaH-8beta-O-(3-acetoxy-2-methylbutyryl)germacra-3(4)E-en-5beta-ol|trijugin F
(8R,9S,22R)-3-ethoxy-3-oxo-9,19-cyclo-3,4-secolanosta-4(28),6,24-trien-26-oic acid 22,26-lactone
(2S,3R,5R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,6-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
(2S,3R,10R,13R,14S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,5-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
(2S,3R,5R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,6-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
(2S,3R,10R,13R,14S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,5-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one [IIN-based on: CCMSLIB00000847804]
(2S,3R,10R,13R,14S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,5-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one [IIN-based: Match]
Gly Lys Lys Tyr
Gly Lys Tyr Lys
Gly Tyr Lys Lys
His Ile Ile Ile
His Ile Ile Leu
His Ile Leu Ile
His Ile Leu Leu
His Leu Ile Ile
His Leu Ile Leu
His Leu Leu Ile
His Leu Leu Leu
Ile His Ile Ile
Ile His Ile Leu
Ile His Leu Ile
Ile His Leu Leu
Ile Ile His Ile
Ile Ile His Leu
Ile Ile Ile His
Ile Ile Leu His
Ile Ile Ser Tyr
Ile Ile Tyr Ser
Ile Leu His Ile
Ile Leu His Leu
Ile Leu Ile His
Ile Leu Leu His
Ile Leu Ser Tyr
Ile Leu Tyr Ser
Ile Ser Ile Tyr
Ile Ser Leu Tyr
Ile Ser Tyr Ile
Ile Ser Tyr Leu
Ile Thr Val Tyr
Ile Thr Tyr Val
Ile Val Thr Tyr
Ile Val Tyr Thr
Ile Tyr Ile Ser
Ile Tyr Leu Ser
Ile Tyr Ser Ile
Ile Tyr Ser Leu
Ile Tyr Thr Val
Ile Tyr Val Thr
Lys Gly Lys Tyr
Lys Gly Tyr Lys
Lys Lys Gly Tyr
Lys Lys Tyr Gly
Lys Tyr Gly Lys
Lys Tyr Lys Gly
Leu His Ile Ile
Leu His Ile Leu
Leu His Leu Ile
Leu His Leu Leu
Leu Ile His Ile
Leu Ile His Leu
Leu Ile Ile His
Leu Ile Leu His
Leu Ile Ser Tyr
Leu Ile Tyr Ser
Leu Leu His Ile
Leu Leu His Leu
Leu Leu Ile His
Leu Leu Leu His
Leu Leu Ser Tyr
Leu Leu Tyr Ser
Leu Ser Ile Tyr
Leu Ser Leu Tyr
Leu Ser Tyr Ile
Leu Ser Tyr Leu
Leu Thr Val Tyr
Leu Thr Tyr Val
Leu Val Thr Tyr
Leu Val Tyr Thr
Leu Tyr Ile Ser
Leu Tyr Leu Ser
Leu Tyr Ser Ile
Leu Tyr Ser Leu
Leu Tyr Thr Val
Leu Tyr Val Thr
Ser Ile Ile Tyr
Ser Ile Leu Tyr
Ser Ile Tyr Ile
Ser Ile Tyr Leu
Ser Leu Ile Tyr
Ser Leu Leu Tyr
Ser Leu Tyr Ile
Ser Leu Tyr Leu
Ser Tyr Ile Ile
Ser Tyr Ile Leu
Ser Tyr Leu Ile
Ser Tyr Leu Leu
Thr Ile Val Tyr
Thr Ile Tyr Val
Thr Leu Val Tyr
Thr Leu Tyr Val
Thr Val Ile Tyr
Thr Val Leu Tyr
Thr Val Tyr Ile
Thr Val Tyr Leu
Thr Tyr Ile Val
Thr Tyr Leu Val
Thr Tyr Val Ile
Thr Tyr Val Leu
Val Ile Thr Tyr
Val Ile Tyr Thr
Val Leu Thr Tyr
Val Leu Tyr Thr
Val Thr Ile Tyr
Val Thr Leu Tyr
Val Thr Tyr Ile
Val Thr Tyr Leu
Val Tyr Ile Thr
Val Tyr Leu Thr
Val Tyr Thr Ile
Val Tyr Thr Leu
Tyr Gly Lys Lys
Tyr Ile Ile Ser
Tyr Ile Leu Ser
Tyr Ile Ser Ile
Tyr Ile Ser Leu
Tyr Ile Thr Val
Tyr Ile Val Thr
Tyr Lys Gly Lys
Tyr Lys Lys Gly
Tyr Leu Ile Ser
Tyr Leu Leu Ser
Tyr Leu Ser Ile
Tyr Leu Ser Leu
Tyr Leu Thr Val
Tyr Leu Val Thr
Tyr Ser Ile Ile
Tyr Ser Ile Leu
Tyr Ser Leu Ile
Tyr Ser Leu Leu
Tyr Thr Ile Val
Tyr Thr Leu Val
Tyr Thr Val Ile
Tyr Thr Val Leu
Tyr Val Ile Thr
Tyr Val Leu Thr
Tyr Val Thr Ile
Tyr Val Thr Leu
(5Z,7E)-(1S,3R)-18-[m-(1-hydroxy-1-methylethyl)-benzyloxy]-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
Atocalcitol
(3b,4b,11b,14b)-11-Ethoxy-3,4-epoxy-14-hydroxy-12-cyathen-15-al 14-xyloside
Cyathsterone D
Guanethidine sulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
8-Amino-1-4-(4-dibutylaminophenylazo)phenylazonaphthalen-2-ol
[(2R)-1-hydroxy-3-phosphonooxypropan-2-yl] docosanoate
2-[[(2R)-3-[(Z)-hexadec-9-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[(E)-hexadec-9-enoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[3-carboxy-2-[(E)-7-[5-hydroxy-2-[(1E,5Z)-3-hydroxyocta-1,5-dienyl]-3-oxocyclopentyl]hept-5-enoyl]oxypropyl]-trimethylazanium
(10E,12Z,16Z)-7-hydroxy-5,6,6,10,14,16-hexamethylspiro[2,20-dioxatricyclo[17.3.1.04,9]tricosa-4(9),5,7,10,12,16-hexaene-21,2-oxane]-3-one
2-[[3-[(E)-hexadec-9-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
Guanethidine bisulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
3-(4-ethoxyphenyl)-1-[3-(4-morpholinyl)propyl]-1-[(1-propyl-3,4-dihydro-2H-quinolin-6-yl)methyl]urea
(2R,3R,3aS,5aR,5bS,7Z,13R,14S,19E,20aS,21aR,21bR)-3-ethyl-13,22-dihydroxy-2-methyl-2,3,3a,5a,5b,6,10,11,12,13,14,15,20a,21,21a,21b-hexadecahydro-1H-14,17-(metheno)-as-indaceno[3,2-k][1,6]diazacycloheptadecine-9,16,18(17H)-trione
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-phenylurea
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
1-[(5S,6S,9S)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5S,6S,9R)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-phenylurea
(2S,3R,10R,13R,14S)-2,3,14-Trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,5-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
1-[(5R,6R,9R)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6R,9S)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
O-[1-O-[(E)-9-Hexadecenoyl]-L-glycero-3-phospho]choline
2-[[(2R)-2-[(Z)-hexadec-9-enoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2,3-dihydroxypropyl [2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] hydrogen phosphate
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) octadecanoate
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate
(1-Acetyloxy-3-phosphonooxypropan-2-yl) nonadecanoate
(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate
(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) dodecanoate
(1-Octanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate
(1-Decanoyloxy-3-phosphonooxypropan-2-yl) undecanoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] undecanoate
2-[[3-[(Z)-hexadec-9-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] undecanoate
2-[[2-[(Z)-hexadec-4-enoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-acetyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-acetyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-propanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] tridecanoate
2,3,14-Trihydroxy-10,13-dimethyl-17-(2,3,6-trihydroxy-5,6-dimethylheptan-2-yl)-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
(3z,3as,5ar,7s,9ar,9bs)-3-[(3e,5e)-6,10-dimethyl-7-oxoundeca-3,5,9-trien-2-ylidene]-3a,6,6,9a-tetramethyl-2-oxo-octahydrocyclopenta[a]naphthalen-7-yl acetate
1,3-dihydroxypropan-2-yl 7-(acetyloxy)-8-[(acetyloxy)methyl]-4b,8,10a-trimethyl-2-methylidene-decahydrophenanthrene-1-carboxylate
(1s,2r,4r)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6ah,7h,8h,10ah-benzo[c]isochromene-2-carboxylate
1-[5-(2h-1,3-benzodioxol-5-yl)-4-pentyl-6-(piperidine-1-carbonyl)cyclohex-2-ene-1-carbonyl]piperidine
1-isopropyl-4-methylcyclohex-3-en-1-yl 1-hydroxy-6,6,9-trimethyl-3-pentyl-6ah,7h,8h,10ah-benzo[c]isochromene-2-carboxylate
1-(2,3-dihydroxy-5,6-dimethylheptan-2-yl)-3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(1s,3as,3br,5as,9as,9bs,11r,11as)-1-[(2s,3r,5r)-1-chloro-2,3-dihydroxy-5-[(1s,2r)-2-methylcyclopropyl]hexan-2-yl]-11-hydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one
(1r,2s,4s)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6ah,7h,8h,10ah-benzo[c]isochromene-2-carboxylate
[(2r,3r,4s,5r,6s)-6-{[(1s,4s,4ar,8as)-1,6-dimethyl-4-[(2r)-6-methylhept-5-en-2-yl]-3,4,4a,7,8,8a-hexahydro-2h-naphthalen-1-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate
ethyl 3-[(1s,4r,5r,8s,9r,12s,13r)-4,8-dimethyl-5-[(1s)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradec-10-en-13-yl]propanoate
(1s,3as,5ar,7r,8s,9ar,9br,10r,11ar)-1-[(2r,3r)-2,3-dihydroxy-5,6-dimethylheptan-2-yl]-3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(3z)-3a,6,6,9a-tetramethyl-3-(6-methyl-7,10-dioxoundeca-3,5,8-trien-2-ylidene)-2-oxo-octahydrocyclopenta[a]naphthalen-7-yl acetate
3-{[5-(2-hydroxy-2,5,8a-trimethyl-5-{[(3-methylbut-2-enoyl)oxy]methyl}-hexahydro-1h-naphthalen-1-yl)-3-methylpentyl]oxy}-3-oxopropanoic acid
ethyl 3-{4,8-dimethyl-5-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradec-10-en-13-yl}propanoate
(2s,3r,4s,5s,6r)-4-(acetyloxy)-5-hydroxy-6-methyl-2-{[(2r)-6-methyl-2-[(1s)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-yl]oxy}oxan-3-yl (2r)-2-methylbutanoate
(3e,5s,7s,8r,9s,10s,11r,13r,15r,16s,18z)-11-ethenyl-2,7,20,27-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaen-28-one
(3e,5e,7s,8r,10s,15r,16z,18z)-11-ethyl-7,20,27,28-tetrahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1(28),3,5,16,18,20,26-heptaen-2-one
(1s,3as,5as,7r,8s,9ar,11ar)-3a,5a,7,8-tetrahydroxy-9a,11a-dimethyl-1-[(2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl]-1h,2h,3h,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-5-one
(3e,5r,8s,9r,10r,13s,15s,16r,18z,25s)-11-ethyl-2,20,27-trihydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione
5-{[4-(acetyloxy)-1-(2-hydroxypropan-2-yl)-10-methyl-1h,2h,3h,3ah,4h,7h,8h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid
methyl 3-{11,15-dimethyl-14-[1-(4-methylfuran-2-yl)propan-2-yl]-5-methylidene-6-oxo-7-oxapentacyclo[8.7.0.0¹,³.0⁴,⁸.0¹¹,¹⁵]heptadecan-3-yl}propanoate
25- deoxysodium makisterone A
{"Ingredient_id": "HBIN004610","Ingredient_name": "25- deoxysodium makisterone A","Alias": "NA","Ingredient_formula": "C28H46O7","Ingredient_Smile": "CC(CC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O)C(C)(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40221","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2S,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyloxane-3,5-diol
{"Ingredient_id": "HBIN006655","Ingredient_name": "(2S,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyloxane-3,5-diol","Alias": "(2S,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyl-tetrahydropyran-3,5-diol; (2S,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyl-oxane-3,5-diol; (2S,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyltetrahydropyran-3,5-diol","Ingredient_formula": "C28H46O7","Ingredient_Smile": "NA","Ingredient_weight": "494.66","OB_score": "21.59533771","CAS_id": "116709-66-1","SymMap_id": "SMIT07406","TCMID_id": "NA","TCMSP_id": "MOL005682","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
allothiobinupharidine
{"Ingredient_id": "HBIN015239","Ingredient_name": "allothiobinupharidine","Alias": "NA","Ingredient_formula": "C30H42N2O2S","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6999","PubChem_id": "NA","DrugBank_id": "NA"}